Issue Date: April 7, 2014
GSK To Expand Across Africa
Seeing human need and business opportunity, GlaxoSmithKline is investing more than $200 million over five years in sub-Saharan Africa.
“We are setting out further steps to tackle Africa’s dual health burden of infectious and emerging noncommunicable diseases and help build crucial capacity to underpin the development of the health care sector in the region,” GSK CEO Andrew Witty said at the 5th EU-Africa Business Forum in Brussels last . . .
You Do Not Have Access to C&EN Protected Content.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society